Exchange: NASDAQ·Updated 06:55 AM EDT
MDGL logo

MDGL Madrigal Pharmaceuticals Inc

$534.00
$0.88
(0.17%)
Pre-Market
Prev Close $533.12
EarningsNov 4
Mkt Cap$12.63B
Vol626.00

About MDGL

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of therapeutics for metabolic dysfunction-associated steatohepatitis. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.
47

Neutral Sentiment

How do you feel about MDGL?

Advertisement|Remove ads.